Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
Acquiring Company
Myriad Genetics
Acquired Company
Intermountain Precision Genomics
Salt Lake CitySaint GeorgeBiotechnologyHealth CareMedicalBiotechnologyHealth CareGeneticsDescription
Myriad Genetics, Inc. has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah. The acquisition is expected to bring new opportunities for innovation, growth, and continued development of Myriad's oncology portfolio.
Quick answer
Myriad Genetics is acquiring Intermountain Precision Genomics, announced January 18, 2024. Myriad Genetics is based in Salt Lake City, Utah, United States.
- How much did Myriad Genetics pay for Intermountain Precision Genomics?
- The deal value was not disclosed.
- What does Myriad Genetics do?
- Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all.
- Where are Myriad Genetics and Intermountain Precision Genomics based?
- Myriad Genetics is based in Salt Lake City, Utah, United States. Intermountain Precision Genomics is based in Saint George, Utah, United States.
- Who are the decision-makers at Myriad Genetics?
- Fundz holds 1 contact at Myriad Genetics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Genetics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
- Frontpoint Health finalizes acquisition of High Plains Senior Care Group to expand its presence and services (February 29, 2024)
- Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform (February 26, 2024)
- Petauri™ Acquires FORCE Communications (February 14, 2024)
- Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals (February 6, 2024)
Who to call at Myriad Genetics, and when
When Myriad Genetics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Myriad Genetics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Myriad Genetics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Myriad Genetics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Myriad Genetics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Intermountain Precision Genomics?
Intermountain Precision Genomics was acquired by Myriad Genetics, based in Salt Lake City. The deal was reported on January 18, 2024. Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics is publicly traded (MYGN) and operates in Biotechnology.
When did Myriad Genetics acquire Intermountain Precision Genomics?
Myriad Genetics's acquisition of Intermountain Precision Genomics was reported on January 18, 2024. Myriad Genetics, Inc. has entered into a definitive agreement to acquire select assets from Intermountain Precision Genomics’ laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Intermountain Precision Genomics do?
Intermountain Precision Genomics is a laboratory business that provides the Precise™ Tumor Test, the Precise Liquid Test, and operates a CLIA-certified laboratory in St. George, Utah. It is privately held, operating in Biotechnology, and is based in Saint George.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.